These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 37402003

  • 21. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ, Gan YG, Zhou JL, Liu JQ, Cao WG, Cheng SM, Bai DM, Wang MZ, Gao FQ, Zhou SM.
    World J Gastroenterol; 2019 Mar 28; 25(12):1513-1523. PubMed ID: 30948914
    [Abstract] [Full Text] [Related]

  • 22. Improved free-breathing liver fat and iron quantification using a 2D chemical shift-encoded MRI with flip angle modulation and motion-corrected averaging.
    Starekova J, Zhao R, Colgan TJ, Johnson KM, Rehm JL, Wells SA, Reeder SB, Hernando D.
    Eur Radiol; 2022 Aug 28; 32(8):5458-5467. PubMed ID: 35307745
    [Abstract] [Full Text] [Related]

  • 23. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction.
    Baek J, Basavarajappa L, Margolis R, Arthur L, Li J, Hoyt K, Parker KJ.
    Med Phys; 2024 Feb 28; 51(2):1313-1325. PubMed ID: 37503961
    [Abstract] [Full Text] [Related]

  • 24. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC, Hooker C, Hooker JC, Bass E, Haufe W, Schlein A, Covarrubias Y, Heba E, Bydder M, Wolfson T, Gamst A, Loomba R, Schwimmer J, Hernando D, Reeder SB, Middleton M, Sirlin CB, Hamilton G.
    J Magn Reson Imaging; 2019 Jan 28; 49(1):229-238. PubMed ID: 29707848
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Cassinotto C, Jacq T, Anselme S, Ursic-Bedoya J, Blanc P, Faure S, Belgour A, Guiu B.
    Radiology; 2022 Nov 28; 305(2):353-361. PubMed ID: 35819322
    [Abstract] [Full Text] [Related]

  • 26. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK, Lee JM, Joo I, Park SJ.
    Korean J Radiol; 2021 Jul 28; 22(7):1077-1086. PubMed ID: 33739636
    [Abstract] [Full Text] [Related]

  • 27. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    Kubale R, Schneider G, Lessenich CPN, Buecker A, Wassenberg S, Torres G, Gurung A, Hall T, Labyed Y.
    AJR Am J Roentgenol; 2024 Jun 28; 222(6):e2330775. PubMed ID: 38506537
    [Abstract] [Full Text] [Related]

  • 28. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.
    Zalcman M, Barth RA, Rubesova E.
    Pediatr Radiol; 2023 Nov 28; 53(12):2466-2475. PubMed ID: 37667050
    [Abstract] [Full Text] [Related]

  • 29. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods.
    Park S, Kwon JH, Kim SY, Kang JH, Chung JI, Jang JK, Jang HY, Shim JH, Lee SS, Kim KW, Song GW.
    Korean J Radiol; 2022 Dec 28; 23(12):1260-1268. PubMed ID: 36447414
    [Abstract] [Full Text] [Related]

  • 30. Application of the magnetic resonance 3D multiecho Dixon sequence for quantifying hepatic iron overload and steatosis in patients with thalassemia.
    Zhao F, Chen Y, Zhou T, Tang C, Huang J, Zhang H, Kannengiesser S, Long L.
    Magn Reson Imaging; 2024 Sep 28; 111():28-34. PubMed ID: 38492786
    [Abstract] [Full Text] [Related]

  • 31. Comparative analysis of hepatic fat quantification across 5 T, 3 T and 1.5 T: A study on consistency and feasibility.
    Liu J, Wang Z, Yu D, Yang Y, Li Z, Wang X, Yang Y, Cheng C, Zou C, Gan J.
    Eur J Radiol; 2024 Nov 28; 180():111709. PubMed ID: 39222564
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease.
    Middleton MS, Van Natta ML, Heba ER, Alazraki A, Trout AT, Masand P, Brunt EM, Kleiner DE, Doo E, Tonascia J, Lavine JE, Shen W, Hamilton G, Schwimmer JB, Sirlin CB, NASH Clinical Research Network.
    Hepatology; 2018 Mar 28; 67(3):858-872. PubMed ID: 29028128
    [Abstract] [Full Text] [Related]

  • 33. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
    Di Martino M, Pacifico L, Bezzi M, Di Miscio R, Sacconi B, Chiesa C, Catalano C.
    World J Gastroenterol; 2016 Oct 21; 22(39):8812-8819. PubMed ID: 27818597
    [Abstract] [Full Text] [Related]

  • 34. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M.
    Radiology; 2013 Jun 21; 267(3):767-75. PubMed ID: 23382293
    [Abstract] [Full Text] [Related]

  • 35. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR, Thapaliya S, Tkach JA, Trout AT.
    AJR Am J Roentgenol; 2022 Nov 21; 219(5):784-791. PubMed ID: 35674351
    [Abstract] [Full Text] [Related]

  • 36. Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease.
    Sim KC, Kim MJ, Cho Y, Kim HJ, Park BJ, Sung DJ, Han NY, Han YE, Kim TH, Lee YJ.
    J Korean Med Sci; 2022 Dec 19; 37(49):e339. PubMed ID: 36536543
    [Abstract] [Full Text] [Related]

  • 37. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
    Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB.
    Radiology; 2013 May 19; 267(2):422-31. PubMed ID: 23382291
    [Abstract] [Full Text] [Related]

  • 38. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    Pickhardt PJ, Graffy PM, Reeder SB, Hernando D, Li K.
    AJR Am J Roentgenol; 2018 Sep 19; 211(3):W151-W157. PubMed ID: 30016142
    [Abstract] [Full Text] [Related]

  • 39. Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study.
    Yang A, Zhu X, Zhang L, Zhang D, Jin M, Lv G, Ding Y.
    BMC Gastroenterol; 2024 Oct 14; 24(1):365. PubMed ID: 39402469
    [Abstract] [Full Text] [Related]

  • 40. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR, Wolfson T, Gamst AC, Fowler KJ, Ohliger M, Shah SN, Alazraki A, Trout AT, Behling C, Allende DS, Loomba R, Sanyal A, Schwimmer J, Lavine JE, Shen W, Tonascia J, Van Natta ML, Mamidipalli A, Hooker J, Kowdley KV, Middleton MS, Sirlin CB, NASH Clinical Research Network (NASH CRN)Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA..
    J Magn Reson Imaging; 2019 May 14; 49(5):1456-1466. PubMed ID: 30318834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.